Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene

被引:195
作者
Grünig, E
Janssen, B
Mereles, D
Barth, U
Borst, MM
Vogt, IR
Fischer, C
Olschewski, H
Kuecherer, HF
Kübler, W
机构
[1] Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany
[3] Univ Giessen, Dept Internal Med 2, Giessen, Germany
关键词
hypertension; pulmonary; echocardiography; genetics;
D O I
10.1161/01.CIR.102.10.1145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Familial primary pulmonary hypertension (PPH) is an autosomal-dominant inherited disease with incomplete penetrance and poor prognosis. This study was performed to examine whether asymptomatic carriers of a mutated PPH gene can be identified at an early stage by their pulmonary artery systolic pressure (PASP) response to exercise. Methods and Results-Stress Doppler echocardiography during supine bicycle exercise and genetic linkage analysis were performed on 52 members of 2 families with PPH. In 4 PPH patients, the mean PASP was increased at rest (73+/16 mm Hg). Fourteen additional family members with normal PASP at rest revealed an abnormal PASP response to exercise (from 23+/-4 to 56+/-11 mm Hg) without secondary cause (abnormal response [AR] group). Twenty-seven other members (NR group) revealed a normal PASP response (maximal pressure <40 mm Hg) to exercise (from 24+/-4 to 37+/-3 mm Hg, P<0.0001), All 14 AR but only 2 NR members shared the risk haplotype with the PPH patients. The molecular genetic analysis supported linkage to chromosome 2q31-32 with a logarithm of the odds score of 4.4 when the 4 patients and the 14 AR members were classified as affected, Conclusions-We conclude that the pathological rise of PASP in asymptomatic family members is linked to chromosome 2q31-32 and is probably an early sign of PPH. Therefore, stress Doppler echocardiography may be a useful tool to identify persons at risk for PPH even before pulmonary artery pressures at rest are elevated.
引用
收藏
页码:1145 / 1150
页数:6
相关论文
共 23 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   ABNORMAL PULMONARY-ARTERY PRESSURE PROFILE AFTER CARDIAC TRANSPLANTATION - AN EXERCISE DOPPLER-ECHOCARDIOGRAPHIC STUDY [J].
BARBANT, SD ;
REDBERG, RF ;
TUCKER, KJ ;
CHATTERJEE, K ;
DEMARCO, T ;
FOSTER, E ;
SCHILLER, NB .
AMERICAN HEART JOURNAL, 1995, 129 (06) :1185-1192
[3]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[4]   DETERMINATION OF RIGHT ATRIAL AND RIGHT VENTRICULAR SIZE BY 2-DIMENSIONAL ECHOCARDIOGRAPHY [J].
BOMMER, W ;
WEINERT, L ;
NEUMANN, A ;
NEEF, J ;
MASON, DT ;
DEMARIA, A .
CIRCULATION, 1979, 60 (01) :91-100
[5]   SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].
DALONZO, GE ;
BARST, RJ ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KERNIS, JT ;
LEVY, PS ;
PIETRA, GG ;
REID, LM ;
REEVES, JT ;
RICH, S ;
VREIM, CE ;
WILLIAMS, GW ;
WU, M .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349
[6]   Primary pulmonary hypertension [J].
Gaine, SP ;
Rubin, LJ .
LANCET, 1998, 352 (9129) :719-725
[7]   Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema [J].
Grünig, E ;
Mereles, D ;
Hildebrandt, W ;
Swenson, ER ;
Kübler, W ;
Kuecherer, H ;
Bärtsch, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :980-987
[8]  
GURTNER HP, 1975, PROG RESPIR RES, V9, P295
[9]  
HATANO S, 1976, CARDIOVASC DIS, V146, P79
[10]   Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension [J].
Higenbottam, T ;
Butt, AY ;
McMahon, A ;
Westerbeck, R ;
Sharples, L .
HEART, 1998, 80 (02) :151-155